• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Endocare

Endocare

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: Analysts see these large-cap U.S. stocks rising at least 30% in 2017

    UPDATE: Analysts see these large-cap U.S. stocks rising at least 30% in 2017

  2. UPDATE: Analysts see these large-cap U.S. -2-

    UPDATE: Analysts see these large-cap U.S. -2-

  3. Endodontic Supplies 2015-2022 - Global Strategic Business Report 2016 - Research and Markets

    Endodontic Supplies 2015-2022 - Global Strategic Business Report 2016 - Research and Markets

  4. EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endo International plc

    EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endo International plc

  5. The Market: Exaggerated Woes

    Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...

  6. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  7. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

  8. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.